# Papers

**Canonical URL:** https://scholariq.org/papers/  
**Records in this collection:** 136,412

Showing 200 of 136,412.

- [The PRISMA 2020 statement: an updated guideline for reporting systematic reviews](https://scholariq.org/papers/the-prisma-2020-statement-an-updated-guideline-for-reporting-systematic-reviews/)
- [Measuring inconsistency in meta-analyses](https://scholariq.org/papers/measuring-inconsistency-in-meta-analyses/)
- [ImageNet: A large-scale hierarchical image database](https://scholariq.org/papers/imagenet-a-large-scale-hierarchical-image-database/)
- [Regression Shrinkage and Selection Via the Lasso](https://scholariq.org/papers/regression-shrinkage-and-selection-via-the-lasso/)
- [The PHQ-9](https://scholariq.org/papers/the-phq-9/)
- [Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups](https://scholariq.org/papers/consolidated-criteria-for-reporting-qualitative-research-coreq-a-32-item/)
- [ImageNet Large Scale Visual Recognition Challenge](https://scholariq.org/papers/imagenet-large-scale-visual-recognition-challenge/)
- [An Introduction to the Bootstrap](https://scholariq.org/papers/an-introduction-to-the-bootstrap/)
- [The Cochrane Collaboration's tool for assessing risk of bias in randomised trials](https://scholariq.org/papers/the-cochrane-collaboration-s-tool-for-assessing-risk-of-bias-in-randomised/)
- [A Brief Measure for Assessing Generalized Anxiety Disorder](https://scholariq.org/papers/a-brief-measure-for-assessing-generalized-anxiety-disorder/)
- [RoB 2: a revised tool for assessing risk of bias in randomised trials](https://scholariq.org/papers/rob-2-a-revised-tool-for-assessing-risk-of-bias-in-randomised-trials/)
- [Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man](https://scholariq.org/papers/homeostasis-model-assessment-insulin-resistance-and-cell-function-from-fasting/)
- [Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study](https://scholariq.org/papers/clinical-course-and-risk-factors-for-mortality-of-adult-inpatients-with-covid-19/)
- [The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration](https://scholariq.org/papers/the-prisma-statement-for-reporting-systematic-reviews-and-meta-analyses-of-4/)
- [Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement](https://scholariq.org/papers/preferred-reporting-items-for-systematic-review-and-meta-analysis-protocols/)
- [A New Equation to Estimate Glomerular Filtration Rate](https://scholariq.org/papers/a-new-equation-to-estimate-glomerular-filtration-rate/)
- [Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2](https://scholariq.org/papers/reproducible-interactive-scalable-and-extensible-microbiome-data-science-using/)
- [The Elements of Statistical Learning](https://scholariq.org/papers/the-elements-of-statistical-learning/)
- [The Elements of Statistical Learning](https://scholariq.org/papers/the-elements-of-statistical-learning-2/)
- [A pneumonia outbreak associated with a new coronavirus of probable bat origin](https://scholariq.org/papers/a-pneumonia-outbreak-associated-with-a-new-coronavirus-of-probable-bat-origin/)
- [GRADE: an emerging consensus on rating quality of evidence and strength of recommendations](https://scholariq.org/papers/grade-an-emerging-consensus-on-rating-quality-of-evidence-and-strength-of/)
- [The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies](https://scholariq.org/papers/the-strengthening-the-reporting-of-observational-studies-in-epidemiology-strobe-3/)
- [A global reference for human genetic variation](https://scholariq.org/papers/a-global-reference-for-human-genetic-variation/)
- [An integrated encyclopedia of DNA elements in the human genome](https://scholariq.org/papers/an-integrated-encyclopedia-of-dna-elements-in-the-human-genome/)
- [Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019](https://scholariq.org/papers/global-burden-of-369-diseases-and-injuries-in-204-countries-and-territories-1990/)
- [Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.](https://scholariq.org/papers/corrigendum-to-2021-esc-guidelines-for-the-diagnosis-and-treatment-of-acute-and/)
- [ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions](https://scholariq.org/papers/robins-i-a-tool-for-assessing-risk-of-bias-in-non-randomised-studies-of/)
- [The Elements of Statistical Learning: Data Mining, Inference, and Prediction](https://scholariq.org/papers/the-elements-of-statistical-learning-data-mining-inference-and-prediction/)
- [The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies](https://scholariq.org/papers/the-strengthening-the-reporting-of-observational-studies-in-epidemiology-strobe-2/)
- [Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics](https://scholariq.org/papers/investigation-of-the-freely-available-easy-to-use-software-ezr-for-medical/)
- [Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging](https://scholariq.org/papers/recommendations-for-cardiac-chamber-quantification-by-echocardiography-in-adults/)
- [Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia](https://scholariq.org/papers/early-transmission-dynamics-in-wuhan-china-of-novel-coronavirus-infected/)
- [The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration](https://scholariq.org/papers/the-prisma-statement-for-reporting-systematic-reviews-and-meta-analyses-of-2/)
- [Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement](https://scholariq.org/papers/minimal-criteria-for-defining-multipotent-mesenchymal-stromal-cells-the/)
- [The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies](https://scholariq.org/papers/the-strengthening-the-reporting-of-observational-studies-in-epidemiology-strobe/)
- [Regularization Paths for Generalized Linear Models via Coordinate Descent](https://scholariq.org/papers/regularization-paths-for-generalized-linear-models-via-coordinate-descent/)
- [A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale](https://scholariq.org/papers/a-new-method-for-measuring-daytime-sleepiness-the-epworth-sleepiness-scale/)
- [The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies](https://scholariq.org/papers/the-strengthening-the-reporting-of-observational-studies-in-epidemiology-strobe-4/)
- [Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis](https://scholariq.org/papers/global-burden-of-bacterial-antimicrobial-resistance-in-2019-a-systematic/)
- [ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data](https://scholariq.org/papers/annovar-functional-annotation-of-genetic-variants-from-high-throughput/)
- [Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review](https://scholariq.org/papers/adverse-renal-effects-of-immune-checkpoint-inhibitors-a-narrative-review/)
- [A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation](https://scholariq.org/papers/a-more-accurate-method-to-estimate-glomerular-filtration-rate-from-serum/)
- [PhysioBank, PhysioToolkit, and PhysioNet](https://scholariq.org/papers/physiobank-physiotoolkit-and-physionet/)
- [Robust enumeration of cell subsets from tissue expression profiles](https://scholariq.org/papers/robust-enumeration-of-cell-subsets-from-tissue-expression-profiles/)
- [Sarcopenia: revised European consensus on definition and diagnosis](https://scholariq.org/papers/sarcopenia-revised-european-consensus-on-definition-and-diagnosis/)
- [Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010](https://scholariq.org/papers/global-and-regional-mortality-from-235-causes-of-death-for-20-age-groups-in-1990/)
- [Guidelines for the Process of Cross-Cultural Adaptation of Self-Report Measures](https://scholariq.org/papers/guidelines-for-the-process-of-cross-cultural-adaptation-of-self-report-measures/)
- [An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest](https://scholariq.org/papers/an-automated-labeling-system-for-subdividing-the-human-cerebral-cortex-on-mri/)
- [Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017](https://scholariq.org/papers/global-regional-and-national-incidence-prevalence-and-years-lived-with-4/)
- [The behaviour change wheel: A new method for characterising and designing behaviour change interventions](https://scholariq.org/papers/the-behaviour-change-wheel-a-new-method-for-characterising-and-designing/)
- [Optical Coherence Tomography](https://scholariq.org/papers/optical-coherence-tomography/)
- [The PRISMA 2020 statement: an updated guideline for reporting systematic reviews](https://scholariq.org/papers/the-prisma-2020-statement-an-updated-guideline-for-reporting-systematic-reviews-3/)
- [A Proportional Hazards Model for the Subdistribution of a Competing Risk](https://scholariq.org/papers/a-proportional-hazards-model-for-the-subdistribution-of-a-competing-risk/)
- [2013 ESH/ESC Guidelines for the management of arterial hypertension](https://scholariq.org/papers/2013-esh-esc-guidelines-for-the-management-of-arterial-hypertension/)
- [The Sequence of the Human Genome](https://scholariq.org/papers/the-sequence-of-the-human-genome/)
- [UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age](https://scholariq.org/papers/uk-biobank-an-open-access-resource-for-identifying-the-causes-of-a-wide-range-of/)
- [Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016](https://scholariq.org/papers/global-regional-and-national-incidence-prevalence-and-years-lived-with-3/)
- [Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation](https://scholariq.org/papers/preferred-reporting-items-for-systematic-review-and-meta-analysis-protocols-2/)
- [Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure](https://scholariq.org/papers/seventh-report-of-the-joint-national-committee-on-prevention-detection/)
- [2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure](https://scholariq.org/papers/2021-esc-guidelines-for-the-diagnosis-and-treatment-of-acute-and-chronic-heart/)
- [Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association](https://scholariq.org/papers/heart-disease-and-stroke-statistics-2017-update-a-report-from-the-american-heart/)
- [Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer](https://scholariq.org/papers/safety-activity-and-immune-correlates-of-anti-pd-1-antibody-in-cancer/)
- [2013 ACCF/AHA Guideline for the Management of Heart Failure](https://scholariq.org/papers/2013-accf-aha-guideline-for-the-management-of-heart-failure/)
- [Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding](https://scholariq.org/papers/genomic-characterisation-and-epidemiology-of-2019-novel-coronavirus-implications/)
- [Bioconductor: open software development for computational biology and bioinformatics](https://scholariq.org/papers/bioconductor-open-software-development-for-computational-biology-and/)
- [Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes](https://scholariq.org/papers/empagliflozin-cardiovascular-outcomes-and-mortality-in-type-2-diabetes/)
- [Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013](https://scholariq.org/papers/global-regional-and-national-prevalence-of-overweight-and-obesity-in-children/)
- [A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010](https://scholariq.org/papers/a-comparative-risk-assessment-of-burden-of-disease-and-injury-attributable-to-67/)
- [The RAST Server: Rapid Annotations using Subsystems Technology](https://scholariq.org/papers/the-rast-server-rapid-annotations-using-subsystems-technology/)
- [Diagnosis and Management of the Metabolic Syndrome](https://scholariq.org/papers/diagnosis-and-management-of-the-metabolic-syndrome/)
- [Sarcopenia: European consensus on definition and diagnosis](https://scholariq.org/papers/sarcopenia-european-consensus-on-definition-and-diagnosis/)
- [An Introduction to Statistical Learning](https://scholariq.org/papers/an-introduction-to-statistical-learning/)
- [Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?](https://scholariq.org/papers/should-we-stop-angiotensin-converting-enzyme-inhibitors-angiotensin-receptor/)
- [The PRISMA 2020 statement: An updated guideline for reporting systematic reviews](https://scholariq.org/papers/the-prisma-2020-statement-an-updated-guideline-for-reporting-systematic-reviews-4/)
- [K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification](https://scholariq.org/papers/k-doqi-clinical-practice-guidelines-for-chronic-kidney-disease-evaluation/)
- [Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis](https://scholariq.org/papers/aspirin-plus-clopidogrel-as-secondary-prevention-after-stroke-or-transient/)
- [Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2](https://scholariq.org/papers/use-of-chemotherapy-plus-a-monoclonal-antibody-against-her2-for-metastatic/)
- [Cortical Surface-Based Analysis](https://scholariq.org/papers/cortical-surface-based-analysis-2/)
- [Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization](https://scholariq.org/papers/chronic-kidney-disease-and-the-risks-of-death-cardiovascular-events-and/)
- [World Health Organization 2020 guidelines on physical activity and sedentary behaviour](https://scholariq.org/papers/world-health-organization-2020-guidelines-on-physical-activity-and-sedentary/)
- [Using the framework method for the analysis of qualitative data in multi-disciplinary health research](https://scholariq.org/papers/using-the-framework-method-for-the-analysis-of-qualitative-data-in-multi/)
- [Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019](https://scholariq.org/papers/global-burden-of-cardiovascular-diseases-and-risk-factors-1990-2019/)
- [Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology](https://scholariq.org/papers/recommendations-for-chamber-quantification-a-report-from-the-american-society-of/)
- [PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews](https://scholariq.org/papers/prisma-2020-explanation-and-elaboration-updated-guidance-and-exemplars-for/)
- [Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines](https://scholariq.org/papers/minimal-information-for-studies-of-extracellular-vesicles-2018-misev2018-a/)
- [Dabigatran versus Warfarin in Patients with Atrial Fibrillation](https://scholariq.org/papers/dabigatran-versus-warfarin-in-patients-with-atrial-fibrillation/)
- [Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications](https://scholariq.org/papers/gene-expression-patterns-of-breast-carcinomas-distinguish-tumor-subclasses-with/)
- [Fast, sensitive and accurate integration of single-cell data with Harmony](https://scholariq.org/papers/fast-sensitive-and-accurate-integration-of-single-cell-data-with-harmony/)
- [A novel potent vasoconstrictor peptide produced by vascular endothelial cells](https://scholariq.org/papers/a-novel-potent-vasoconstrictor-peptide-produced-by-vascular-endothelial-cells/)
- [Observation of a new particle in the search for the Standard Model Higgs boson with the ATLAS detector at the LHC](https://scholariq.org/papers/observation-of-a-new-particle-in-the-search-for-the-standard-model-higgs-boson/)
- [Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide](https://scholariq.org/papers/better-reporting-of-interventions-template-for-intervention-description-and/)
- [Food in the Anthropocene: the EAT–Lancet Commission on healthy diets from sustainable food systems](https://scholariq.org/papers/food-in-the-anthropocene-the-eat-lancet-commission-on-healthy-diets-from/)
- [Significance analysis of microarrays applied to the ionizing radiation response](https://scholariq.org/papers/significance-analysis-of-microarrays-applied-to-the-ionizing-radiation-response/)
- [AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both](https://scholariq.org/papers/amstar-2-a-critical-appraisal-tool-for-systematic-reviews-that-include/)
- [The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration](https://scholariq.org/papers/the-prisma-statement-for-reporting-systematic-reviews-and-meta-analyses-of-3/)
- [GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables](https://scholariq.org/papers/grade-guidelines-1-introduction-grade-evidence-profiles-and-summary-of-findings/)
- [Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition](https://scholariq.org/papers/global-and-regional-diabetes-prevalence-estimates-for-2019-and-projections-for/)
- [Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline](https://scholariq.org/papers/evaluation-treatment-and-prevention-of-vitamin-d-deficiency-an-endocrine-society/)
- [2018 ESC/ESH Guidelines for the management of arterial hypertension](https://scholariq.org/papers/2018-esc-esh-guidelines-for-the-management-of-arterial-hypertension/)
- [The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration](https://scholariq.org/papers/the-prisma-statement-for-reporting-systematic-reviews-and-meta-analyses-of/)
- [Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.](https://scholariq.org/papers/accuracy-of-clinical-diagnosis-of-idiopathic-parkinson-s-disease-a-clinico/)
- [Dementia prevention, intervention, and care: 2020 report of the Lancet Commission](https://scholariq.org/papers/dementia-prevention-intervention-and-care-2020-report-of-the-lancet-commission/)
- [A typology of reviews: an analysis of 14 review types and associated methodologies](https://scholariq.org/papers/a-typology-of-reviews-an-analysis-of-14-review-types-and-associated/)
- [Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies](https://scholariq.org/papers/strengthening-the-reporting-of-observational-studies-in-epidemiology-strobe-2/)
- [The mutational constraint spectrum quantified from variation in 141,456 humans](https://scholariq.org/papers/the-mutational-constraint-spectrum-quantified-from-variation-in-141-456-humans/)
- [The global distribution and burden of dengue](https://scholariq.org/papers/the-global-distribution-and-burden-of-dengue/)
- [The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease](https://scholariq.org/papers/the-diagnosis-of-mild-cognitive-impairment-due-to-alzheimer-s-disease/)
- [Signatures of mutational processes in human cancer](https://scholariq.org/papers/signatures-of-mutational-processes-in-human-cancer/)
- [Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer](https://scholariq.org/papers/pembrolizumab-versus-chemotherapy-for-pd-l1-positive-non-small-cell-lung-cancer/)
- [Statistical significance for genomewide studies](https://scholariq.org/papers/statistical-significance-for-genomewide-studies/)
- [The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies](https://scholariq.org/papers/the-strengthening-the-reporting-of-observational-studies-in-epidemiology-strobe-5/)
- [Perceptual Losses for Real-Time Style Transfer and Super-Resolution](https://scholariq.org/papers/perceptual-losses-for-real-time-style-transfer-and-super-resolution/)
- [2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)](https://scholariq.org/papers/2020-esc-guidelines-for-the-diagnosis-and-management-of-atrial-fibrillation/)
- [IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045](https://scholariq.org/papers/idf-diabetes-atlas-global-regional-and-country-level-diabetes-prevalence/)
- [Observation of a new boson at a mass of 125 GeV with the CMS experiment at the LHC](https://scholariq.org/papers/observation-of-a-new-boson-at-a-mass-of-125-gev-with-the-cms-experiment-at-the/)
- [Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling](https://scholariq.org/papers/distinct-types-of-diffuse-large-b-cell-lymphoma-identified-by-gene-expression/)
- [Adolescence-limited and life-course-persistent antisocial behavior: A developmental taxonomy.](https://scholariq.org/papers/adolescence-limited-and-life-course-persistent-antisocial-behavior-a/)
- [MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS](https://scholariq.org/papers/multivariable-prognostic-models-issues-in-developing-models-evaluating/)
- [Statistical parametric maps in functional imaging: A general linear approach](https://scholariq.org/papers/statistical-parametric-maps-in-functional-imaging-a-general-linear-approach/)
- [2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation](https://scholariq.org/papers/2017-esc-guidelines-for-the-management-of-acute-myocardial-infarction-in/)
- [Surviving Sepsis Campaign](https://scholariq.org/papers/surviving-sepsis-campaign/)
- [Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019](https://scholariq.org/papers/global-burden-of-87-risk-factors-in-204-countries-and-territories-1990-2019-a/)
- [The Amber biomolecular simulation programs](https://scholariq.org/papers/the-amber-biomolecular-simulation-programs/)
- [Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls](https://scholariq.org/papers/genome-wide-association-study-of-14-000-cases-of-seven-common-diseases-and-3-000/)
- [Prediction of Coronary Heart Disease Using Risk Factor Categories](https://scholariq.org/papers/prediction-of-coronary-heart-disease-using-risk-factor-categories/)
- [2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative](https://scholariq.org/papers/2010-rheumatoid-arthritis-classification-criteria-an-american-college-of-2/)
- [Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray](https://scholariq.org/papers/quantitative-monitoring-of-gene-expression-patterns-with-a-complementary-dna/)
- [The american college of rheumatology 1990 criteria for the classification of fibromyalgia](https://scholariq.org/papers/the-american-college-of-rheumatology-1990-criteria-for-the-classification-of/)
- [PD-1 Blockade in Tumors with Mismatch-Repair Deficiency](https://scholariq.org/papers/pd-1-blockade-in-tumors-with-mismatch-repair-deficiency/)
- [Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer](https://scholariq.org/papers/nivolumab-versus-docetaxel-in-advanced-nonsquamous-non-small-cell-lung-cancer/)
- [From local explanations to global understanding with explainable AI for trees](https://scholariq.org/papers/from-local-explanations-to-global-understanding-with-explainable-ai-for-trees/)
- [Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation](https://scholariq.org/papers/rivaroxaban-versus-warfarin-in-nonvalvular-atrial-fibrillation/)
- [<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy](https://scholariq.org/papers/i-egfr-i-mutations-in-lung-cancer-correlation-with-clinical-response-to/)
- [Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association](https://scholariq.org/papers/heart-disease-and-stroke-statistics-2020-update-a-report-from-the-american-heart/)
- [Regression Modeling Strategies](https://scholariq.org/papers/regression-modeling-strategies-2/)
- [Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease](https://scholariq.org/papers/antiinflammatory-therapy-with-canakinumab-for-atherosclerotic-disease/)
- [Quantity and Quality of Exercise for Developing and Maintaining Cardiorespiratory, Musculoskeletal, and Neuromotor Fitness in Apparently Healthy Adults](https://scholariq.org/papers/quantity-and-quality-of-exercise-for-developing-and-maintaining/)
- [Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association](https://scholariq.org/papers/heart-disease-and-stroke-statistics-2019-update-a-report-from-the-american-heart/)
- [The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure](https://scholariq.org/papers/the-effect-of-spironolactone-on-morbidity-and-mortality-in-patients-with-severe/)
- [CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials](https://scholariq.org/papers/consort-2010-explanation-and-elaboration-updated-guidelines-for-reporting/)
- [Whole Brain Segmentation](https://scholariq.org/papers/whole-brain-segmentation/)
- [2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>](https://scholariq.org/papers/2019-esc-eas-guidelines-for-the-management-of-dyslipidaemias-i-lipid/)
- [Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010](https://scholariq.org/papers/disability-adjusted-life-years-dalys-for-291-diseases-and-injuries-in-21-regions/)
- [Apixaban versus Warfarin in Patients with Atrial Fibrillation](https://scholariq.org/papers/apixaban-versus-warfarin-in-patients-with-atrial-fibrillation/)
- [Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China](https://scholariq.org/papers/risk-factors-associated-with-acute-respiratory-distress-syndrome-and-death-in/)
- [Isolation of Putative Progenitor Endothelial Cells for Angiogenesis](https://scholariq.org/papers/isolation-of-putative-progenitor-endothelial-cells-for-angiogenesis/)
- [Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017](https://scholariq.org/papers/global-regional-and-national-age-sex-specific-mortality-for-282-causes-of-death/)
- [<i>Gaia</i> Data Release 2](https://scholariq.org/papers/i-gaia-i-data-release-2/)
- [Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer](https://scholariq.org/papers/nivolumab-versus-docetaxel-in-advanced-squamous-cell-non-small-cell-lung-cancer/)
- [The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity](https://scholariq.org/papers/the-cancer-cell-line-encyclopedia-enables-predictive-modelling-of-anticancer/)
- [Compendium of Physical Activities: an update of activity codes and MET intensities](https://scholariq.org/papers/compendium-of-physical-activities-an-update-of-activity-codes-and-met/)
- [European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention &amp; Rehabilitation (EACPR)](https://scholariq.org/papers/european-guidelines-on-cardiovascular-disease-prevention-in-clinical-practice-5/)
- [ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease](https://scholariq.org/papers/acc-aha-2006-guidelines-for-the-management-of-patients-with-valvular-heart/)
- [Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration](https://scholariq.org/papers/strengthening-the-reporting-of-observational-studies-in-epidemiology-strobe/)
- [Grading quality of evidence and strength of recommendations](https://scholariq.org/papers/grading-quality-of-evidence-and-strength-of-recommendations/)
- [Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)](https://scholariq.org/papers/randomised-trial-of-cholesterol-lowering-in-4444-patients-with-coronary-heart/)
- [Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010](https://scholariq.org/papers/years-lived-with-disability-ylds-for-1160-sequelae-of-289-diseases-and-injuries/)
- [Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging](https://scholariq.org/papers/recommendations-for-cardiac-chamber-quantification-by-echocardiography-in-adults-2/)
- [Construction of a genetic linkage map in man using restriction fragment length polymorphisms.](https://scholariq.org/papers/construction-of-a-genetic-linkage-map-in-man-using-restriction-fragment-length/)
- [ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary](https://scholariq.org/papers/acc-aha-guidelines-for-the-management-of-patients-with-st-elevation-myocardial/)
- [Assessing coping strategies: A theoretically based approach.](https://scholariq.org/papers/assessing-coping-strategies-a-theoretically-based-approach/)
- [Heart disease and stroke statistics--2015 update: a report from the American Heart Association.](https://scholariq.org/papers/heart-disease-and-stroke-statistics-2015-update-a-report-from-the-american-heart/)
- [The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations](https://scholariq.org/papers/the-prisma-extension-statement-for-reporting-of-systematic-reviews-incorporating/)
- [2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation](https://scholariq.org/papers/2015-esc-guidelines-for-the-management-of-acute-coronary-syndromes-in-patients/)
- [GRADE guidelines: 3. Rating the quality of evidence](https://scholariq.org/papers/grade-guidelines-3-rating-the-quality-of-evidence/)
- [Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma](https://scholariq.org/papers/gefitinib-or-carboplatin-paclitaxel-in-pulmonary-adenocarcinoma/)
- [An integrated map of genetic variation from 1,092 human genomes](https://scholariq.org/papers/an-integrated-map-of-genetic-variation-from-1-092-human-genomes/)
- [Integrated genomic analyses of ovarian carcinoma](https://scholariq.org/papers/integrated-genomic-analyses-of-ovarian-carcinoma/)
- [Biological insights from 108 schizophrenia-associated genetic loci](https://scholariq.org/papers/biological-insights-from-108-schizophrenia-associated-genetic-loci/)
- [Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT Gene](https://scholariq.org/papers/influence-of-life-stress-on-depression-moderation-by-a-polymorphism-in-the-5-htt/)
- [The Behavior Change Technique Taxonomy (v1) of 93 Hierarchically Clustered Techniques: Building an International Consensus for the Reporting of Behavior Change Interventions](https://scholariq.org/papers/the-behavior-change-technique-taxonomy-v1-of-93-hierarchically-clustered/)
- [A map of human genome variation from population-scale sequencing](https://scholariq.org/papers/a-map-of-human-genome-variation-from-population-scale-sequencing-2/)
- [p53 Mutations in Human Cancers](https://scholariq.org/papers/p53-mutations-in-human-cancers/)
- [SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials](https://scholariq.org/papers/spirit-2013-statement-defining-standard-protocol-items-for-clinical-trials/)
- [Dexamethasone in Hospitalized Patients with Covid-19.](https://scholariq.org/papers/dexamethasone-in-hospitalized-patients-with-covid-19/)
- [Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer](https://scholariq.org/papers/safety-and-activity-of-anti-pd-l1-antibody-in-patients-with-advanced-cancer/)
- [2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults](https://scholariq.org/papers/2014-evidence-based-guideline-for-the-management-of-high-blood-pressure-in/)
- [The representative concentration pathways: an overview](https://scholariq.org/papers/the-representative-concentration-pathways-an-overview/)
- [Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer](https://scholariq.org/papers/mutational-landscape-determines-sensitivity-to-pd-1-blockade-in-non-small-cell/)
- [Power failure: why small sample size undermines the reliability of neuroscience](https://scholariq.org/papers/power-failure-why-small-sample-size-undermines-the-reliability-of-neuroscience/)
- [Closing the gap in a generation: health equity through action on the social determinants of health](https://scholariq.org/papers/closing-the-gap-in-a-generation-health-equity-through-action-on-the-social/)
- [Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study](https://scholariq.org/papers/global-regional-and-national-sepsis-incidence-and-mortality-1990-2017-analysis/)
- [Effects of Intensive Glucose Lowering in Type 2 Diabetes](https://scholariq.org/papers/effects-of-intensive-glucose-lowering-in-type-2-diabetes/)
- [Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion](https://scholariq.org/papers/spurious-but-systematic-correlations-in-functional-connectivity-mri-networks/)
- [Brain–computer interfaces for communication and control](https://scholariq.org/papers/brain-computer-interfaces-for-communication-and-control/)
- [Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019](https://scholariq.org/papers/global-regional-and-national-burden-of-stroke-and-its-risk-factors-1990-2019-a/)
- [Comprehensive genomic characterization defines human glioblastoma genes and core pathways](https://scholariq.org/papers/comprehensive-genomic-characterization-defines-human-glioblastoma-genes-and-core/)
- [Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes](https://scholariq.org/papers/canagliflozin-and-cardiovascular-and-renal-events-in-type-2-diabetes/)
- [Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015](https://scholariq.org/papers/global-regional-and-national-comparative-risk-assessment-of-79-behavioural/)
- [KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease](https://scholariq.org/papers/kdigo-2024-clinical-practice-guideline-for-the-evaluation-and-management-of/)
- [10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes](https://scholariq.org/papers/10-year-follow-up-of-intensive-glucose-control-in-type-2-diabetes/)
- [Biological effects of essential oils – A review](https://scholariq.org/papers/biological-effects-of-essential-oils-a-review/)
- [WHO Declares COVID-19 a Pandemic.](https://scholariq.org/papers/who-declares-covid-19-a-pandemic/)
- [Global burden of hypertension: analysis of worldwide data](https://scholariq.org/papers/global-burden-of-hypertension-analysis-of-worldwide-data/)
- [Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults](https://scholariq.org/papers/worldwide-trends-in-body-mass-index-underweight-overweight-and-obesity-from-1975/)
- [Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results](https://scholariq.org/papers/movement-disorder-society-sponsored-revision-of-the-unified-parkinson-s-disease/)
- [Dissociable Intrinsic Connectivity Networks for Salience Processing and Executive Control](https://scholariq.org/papers/dissociable-intrinsic-connectivity-networks-for-salience-processing-and/)
- [Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials](https://scholariq.org/papers/recommendations-for-examining-and-interpreting-funnel-plot-asymmetry-in-meta/)
- [MDS clinical diagnostic criteria for Parkinson's disease](https://scholariq.org/papers/mds-clinical-diagnostic-criteria-for-parkinson-s-disease/)
- [General Cardiovascular Risk Profile for Use in Primary Care](https://scholariq.org/papers/general-cardiovascular-risk-profile-for-use-in-primary-care/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex.